Humana (HUM) Q4 2025 (USD): adj. EPS -3.96 (exp. -4.00), Revenue 32.5bln (exp. 32.04bln)
- Q4 adj. benefit ratio 93% (vs 91.3% Y/Y)
COMMENTARY:
- Remains confident in strategy and 2026 membership outlook
GUIDANCE:
- FY EPS view 8.89 (exp. 11.91)
Context
Humana's Q4 earnings report shows an adjusted EPS that slightly beat expectations, alongside stronger revenue than anticipated. However, the FY EPS guidance is significantly below consensus, which could raise concerns about future profitability despite the company's confidence in its strategy and 2026 membership outlook. Traders should monitor how the market reacts to these mixed signals, particularly in light of the forward outlook.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#HUMANA INC#HUM.US#FOREX#EQUITIES#METALS#EU SESSION#MANAGED HEALTH CARE#METALS & MINING#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#HUM#DXY#US EQUITIES